Ralstonia pickettii - Innocent by bystander or a potential threat?

Clinical Microbiology and Infection

Volumn 12, Issue 2, 2006, Pages 99-101

  Stelzmueller, I ^a   Biebl, M ^a   Wiesmayr, S ^a   Eller, M ^a   Hoeller, E ^a   Fille, M ^a   Weiss, G ^a   Lass Floerl, C ^a   Bonatti, Hugo ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antimicrobial susceptibility; Cystic fibrosis patients; Immunocompromised patients; Infections; Ralstonia pickettii; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CYSTIC FIBROSIS; EDITORIAL; HUMAN; IN VITRO STUDY; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RALSTONIA; RALSTONIA PICKETTII; RESPIRATORY TRACT INFECTION; RISK FACTOR; SPUTUM ANALYSIS;

BACTERIA (MICROORGANISMS); RALSTONIA; RALSTONIA PICKETTII;

EID: 33644903802     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01309.x     Document Type: Editorial

References (20)

1. Verschraegen G, Claeys G, Meeus G, Delanghe M. Pseudomonas pickettii as a cause of pseudobacteremia. J Clin Microbiol 1985; 2: 278-279.
2. Coenye T, Vandamme P, LiPua JJ. Infections by Ralstonia species in cystic fibrosis patients: Identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis 2002; 8: 692-696.
3. Zellweger C, Bodmer T, Tauber MG, Muhlemann K. Failure of ceftriaxone in an intravenous drug user with invasive infection due to Ralstonia pickettii. Infection 2004; 32: 246-248.
4. Labarca JA, Trick WE, Peterson CL et al. A multistate nosocomial outbreak of Ralstonia pickettii colonization associated with an intrinsically contaminated respiratory care solution. Clin Infect Dis 1999; 29: 1281-1286.
5. McNeil MM, Solomon SL, Anderson RL et al. Nosocomial Pseudomonas pickettii colonization associated with a contaminated respiratory therapy solution in a special care nursery. J Clin Microbiol 1985; 12: 903-907.
6. Boutros N, Gonullu N, Casetta A, Guibert M, Ingrand D, Lebrun L. Ralstonia pickettii traced in blood culture bottles. J Clin Microbiol 2002; 7: 2666-2667.
7. Fernandez C, Wilhelmi I, Andradas E et al. Nosocomial outbreak of Burkholderia pickettii infection due to a manufactured intravenous product used in three hospitals. Clin Infect Dis 1996; 22: 1092-1095.
8. Kismet E, Atay AA, Demirkaya E et al. Two cases of Ralstonia pickettii bacteremias in a pediatric oncology unit requiring removal of the port-a-caths. J Pediatr Hematol Oncol 2005; 27: 37-38.
9. Daxboeck F, Stadler M, Assadian O, Marko E, Hirschl AM, Koller W. Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays. Med Microbiol 2005; 54: 55-61.
10. Maroye P, Doermann HP, Rogues AM, Gachie JP, Megraud F. Investigations of an outbreak of Ralstonia pickettii in a paediatric hospital by RAPD. J Hosp Infect 2000; 44: 267-272.
11. Woo PC, Wong SS, Yuen KY. Ralstonia pickettii bacteraemia in a cord blood transplant recipient. New Microbiol 2002; 25: 97-102.
12. Marroni M, Pasticci MB, Pantosti A, Colozza MA, Stagni G, Tonato M. Outbreak of infusion-related septicemia by Ralstonia pickettii in the oncology department. Tumori 2003; 89: 575-576.
13. Kendirli T, Ciftci E, Ince E et al. Ralstonia pickettii outbreak associated with contaminated distilled water used for respiratory care in a paediatric intensive care unit. J Hosp Infect 2004; 56: 77-78.
14. Moreira BM, Leobons MB, Pellegrino FL et al. Ralstonia pickettii and Burkolderia cepacia complex bloodstream infections related to infusions of contaminated water for injection. J Hosp Infect 2005; 60: 51-55.
15. Anderson RL, Bland LA, Favero MS et al. Factors associated with Pseudomonas pickettii intrinsic contamination of commercial respiratory therapy solutions marketed as sterile. Appl Environ Microbiol 1985; 12: 1343-1348.
16. Moissenet D, Bingen E, Arlet G, Vu-Thien H. Use of 16S rRNA gene sequencing for identification of 'Pseudomonas -like' isolates from sputum of patients with cystic fibrosis. Pathol Biol 2005; 53: 500-502.
17. Pasticci MB, Baldelli F, Camilli R et al. Pulsed field gel electrophoresis and random amplified polymorphic DNA molecular characterization of Ralstonia pickettii isolates from patients with nosocomial central venous catheter related bacteremia. New Microbiol 2005; 28: 145-149.
18. Hsueh PR, Teng LJ, Pan HJ et al. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol 1998; 36: 2914-2917.
19. Girlich D, Naas T, Nordmann P. OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D beta-lactamase from Ralstonia pickettii. Antimicrob Agents Chemother 2004; 48: 4217-4225.
20. T'Sjoen G, Verschraegen G, Steyaert S, Vogelaers D. Avoidable 'fever of unknown origin' due to Ralstonia pickettii bacteremia. Acta Clin Belg 2001; 56: 51-54.